Kotyark Industries FY26 Profit Rises to ₹19.36 Cr, Board Recommends 50% Dividend

CHEMICALS
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Kotyark Industries FY26 Profit Rises to ₹19.36 Cr, Board Recommends 50% Dividend
Overview

Kotyark Industries has reported its audited FY26 financial results, with consolidated net profit reaching ₹19.36 crore on revenue of ₹314.87 crore. The Board of Directors recommended a final dividend of ₹5 per equity share (50% of face value), subject to shareholder approval. Auditors issued an unmodified opinion on the statements.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Kotyark Industries Reports Strong FY26 Financials, Proposes 50% Dividend

The robust financial performance reported by Kotyark Industries for fiscal year 2026, highlighted by a ₹19.36 crore net profit and ₹314.87 crore revenue, signifies a strong year for its core biodiesel and glycerin operations. This positive result, on which auditors issued an unmodified opinion, has prompted the Board of Directors to recommend a final dividend of ₹5 per equity share (50% of face value), subject to shareholder approval.

Financial Performance Details

Consolidated revenue from operations grew approximately 9.3% to ₹31,487.01 lakh (₹314.87 crore) in FY26, up from ₹28,809.83 lakh in FY25. Consolidated net profit saw a substantial increase of about 33.2%, rising to ₹1,936.40 lakh (₹19.36 crore) from ₹1,453.33 lakh in the previous fiscal year. The proposed dividend payout underscores the company's financial strength and commitment to returning value to shareholders.

Regulatory and Operational Background

Kotyark Industries, operating in the renewable energy sector with a focus on biodiesel, has navigated regulatory matters. In 2017, a ban on retail biodiesel sales by the Rajasthan State Bio-Fuel Authority was challenged by the company and later quashed by the Rajasthan High Court in 2018. More recently, in July 2025, Rajasthan Agriculture Minister Kirodi Lal Meena conducted a surprise inspection at the Sirohi facility, prompting questions on tax compliance, which Kotyark Industries has denied. Despite past and recent scrutiny, the company secured a 'Consent to Operate' for its enhanced production capacity in Rajasthan, valid until April 2034, ensuring operational continuity. The company's shares were also admitted to dealings on the NSE main board on March 12, 2026.

Regulatory Scrutiny and Compliance

While past regulatory issues have been resolved and recent allegations denied, the history of inspections and challenges suggests the importance of ongoing vigilance regarding compliance. Investors may monitor how effectively the company addresses any compliance concerns to maintain operational stability and market confidence.

Industry Peers

Kotyark Industries operates in the specialized biofuels and renewable energy market. Its key competitors include Rajputana Biodiesel, Godavari Biorefineries, GP Petroleums, Kabsons Industries Ltd, and Neptune Petrochemicals, companies active in similar sectors like chemicals and petroleum products.

Looking Ahead

Key factors for investors to watch include shareholder approval of the proposed final dividend at the upcoming Annual General Meeting. Continued monitoring of regulatory compliance, especially in light of recent inspections, will also be important. The company's ability to capitalize on its expanded production capacity and meet growing demand for biofuels will be crucial for its future growth trajectory.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.